Medical Marijuana, Inc. (OTC Pink:MJNA) and HempMedsPX™ – a
corporate portfolio company of Medical Marijuana Inc. and the
exclusive master distributor and contracted marketing company for
CannaVest Corp. and Medical Marijuana, Inc. – are pleased to
announce that the American Academy of Anti-Aging Medicine (A4M) has
approved and is actively promoting HempMedsPX™ as a new Platinum
Elite Sponsor on both the A4M and Worldhealth.net websites. The A4M
is a 501(c)3 non-profit organization with more than 26,000 members
including physicians, scientists, and governmental officials in
over 120 nations. The A4M seeks to disseminate information
concerning innovative science and research as well as treatment
modalities designed to prolong the human lifespan. The online
information portal for the A4M members, Worldhealth.net, is a
leading non-profit source of trusted, non-commercial health
information for doctors and the general public.
The A4M is dedicated to the advancement of technology to detect,
prevent, and treat aging-related disease, and to promote research
into methods to slow and optimize the human aging process. The A4M
is also dedicated to educating physicians, scientists, and members
of the public on biomedical sciences, cutting-edge technologies,
and anti-aging issues. 85% of A4M's membership is physicians, and
the organization is a destination for Board (The American Board of
Anti-Aging and Regenerative Medicine – ABAARM) and Diplomate (The
American Board of Anti-Aging Health Practitioners – ABAAHP)
certifications, as well as a variety of additional Anti-Aging
medicine accreditation programs for healthcare practitioners.
Cannabinoids have been found to have antioxidant
properties. The US Department of Health and Human Services
(HHS) was awarded United States Patent #6,630,507 for CBD and other
cannabinoids on Oct. 7, 2003.
The greatest benefit of A4M Platinum Elite Sponsorship for
Medical Marijuana Inc. and HempMedsPX™ is the access to
governmental decision-makers, groundbreaking scientists, and
innovative physicians who have the ability to medically and
scientifically evaluate and recommend CBD-rich hemp oil products
globally. A variety of market opportunities defined by the A4M
include:
- The anti-aging market is estimated to be worth $292 billion
globally by 2015.
- 10% of the world's population is aged 60+ today, and is
expected to represent 22% by 2050.
- The global nutraceutical market is projected to exceed $243
billion by 2015. -- The current US nutraceutical market is valued
at $17.1 billion.
- Sixty percent (60%) of Americans aged 65+ are pursuing
anti-aging interventions, including hormone replacement therapies
and dietary supplementation.
- Dietary supplement sales were $25 billion in 2010. --
Thirty-three percent (33%) of adults take supplements on the
specific advice of their doctor.
"CBD is recognized as a powerful antioxidant by the U.S.
government's patent on cannabidiol and other cannabinoids," says
Michelle Sides, COO of Medical Marijuana Inc. "HempMedsPX™ is
blazing a trail as the front-runner in both the global anti-aging
and nutraceutical markets by providing the A4M's 26,000 doctors and
scientists with the latest information on the antioxidant
properties of the world's purest and richest CBD hemp oil products.
Our efforts to inform the public about CBD-rich hemp oil products
are significantly accelerated through our newfound alliance with
the A4M. We are extremely honored to be a Platinum Elite Sponsor of
the A4M organization, and we look forward to actively participating
in a full slate of conferences in 2014."
Throughout the year, HempMedsPX™ will exhibit and promote
cannabidiol (CBD)-rich hemp oil products to tens of thousands of
A4M members at the organization's conferences including:
- March 13-16: BHRT Symposium / Fellowship – San Francisco
- April 4-6: Commercial Workshop / BHRT Symposium / Fellowship –
Denver
- May 15-17: Commercial Workshop – Orlando
- September 10-13: BHRT Symposium / Fellowship – Phoenix
- October 16-18: Fellowship Modules and IV Symposium – New
Orleans
- December 11-13: Commercial Workshop – Las Vegas
The A4M is comprised of over 26,000 members from 120 nations
worldwide, as follows:
- 85% are physicians (MD, DO, MBBS)
- 12% are scientists, researchers, and healthcare practitioners;
and
- 3% are governmental officials, members of the working press and
general public
The disciplines of the A4M physician members are
approximately:
- Family Practice, 23%
- General Medicine, 15%
- Endocrinology, 11%
- Internal Medicine, 8%
- Dermatology, 8%
- Plastic Surgery, 6%
- Cardiology, 8%
- Doctors of Osteopathy (D.O.), 6%
- OB-GYN, 5%
- Sports Medicine, 4%
- Orthopedics, 2%
- Emergency Medicine, 2%
- Doctors of Chiropractic (D.C.), 2%
HempMedsPX™ proudly represents the world's first innovative
lines of CBD-rich hemp oil products. On February 9th, HempMedsPX™
continued to establish the Company's brand recognition by
representing the winner of the globally-renowned 2014 High Times
Cannabis Cup competition in Los Angeles for Highest CBD
Concentrate. This extremely competitive international judging event
featured entries by the most prominent growers, breeders and
producers of cannabis and cannabis products. Other significant
industry accolades include first place awards for Highest CBD
Concentrate at the 2013 High Times Cannabis Cup competition in
Amsterdam, the 2013 Seattle High Times Cannabis Cup, and
the 2013 Michigan Medical Marijuana Conference "Green
Cup" contests.
HempMedsPX™'s primary message to the public is that industrial
hemp-derived CBD is non-psychoactive, is readily available online,
and is legal throughout the United States and in more than forty
countries. For more information on CBD-rich hemp oil products,
please visit:
HempMedsPX |
http://www.HempMedsPX.com |
866.273.8502 |
|
Real Scientific Hemp Oil |
http://RealScientificHempOil.com |
866.273.8502 |
|
HempVAP |
http://www.hempVAP.com |
866.273.8502 |
|
Cibdex |
http://www.cibdex.com |
866.273.8502 |
|
Cibaderm |
http://www.cibaderm.com |
866.273.8502 |
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry
innovators, leveraging our team of professionals to source,
evaluate and purchase value-added companies and products, while
allowing them to keep their integrity and entrepreneurial spirit.
We strive to create awareness within our industry, develop
environmentally-friendly, economically sustainable businesses,
while increasing shareholder value. For more information, please
visit the company's website at: www.MedicalMarijuanaInc.com
About HempMedsPX
HempMedsPX offers mainstream marketing, sales, customer
service, and logistics for the cannabis
industry. HempMedsPX is a corporate portfolio company
of Medical Marijuana, Inc. (OTC Pink:MJNA) and the
exclusive master distributor and contracted marketing company
for CannaVest Corp. (OTC:CANV) and Medical Marijuana
Inc. In addition to handling sales and
distribution, HempMedsPX is the communication hub for the
Medical Marijuana Inc. portfolio of companies.
About CannaVest Corp.
CannaVest Corp. is in the business of investing and
developing hemp-based businesses. CannaVest Corp. also
develops, produces, markets and sells end-consumer products to the
nutraceutical industry containing the hemp plant extract,
cannabidiol (CBD). Additionally, the company resells—to third
parties—raw product acquired by CannaVest Corp. pursuant
to the company's supply international relationships.CannaVest
Corp. seeks to take advantage of an emerging worldwide trend
to re-energize the production of industrial hemp and to foster its
many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural
constituents of the hemp plant, and CBD is derived from hemp stalk
and seed. Additional information is available
from OTCMarkets.com or by
visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not
intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of Medical Marijuana, Inc. to
be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products
that are in violation of the United States Controlled Substances
Act (US.CSA). The company does grow, sell and distribute hemp-based
products and are involved with Federally Legal Distribution of
Medical Marijuana-based products within certain international
markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact:
Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
info@smallcapvoice.com
Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Apr 2023 to Apr 2024